Quarterly report pursuant to Section 13 or 15(d)

Composition of Certain Financial Statement Items (Tables)

v3.10.0.1
Composition of Certain Financial Statement Items (Tables)
 3 Months Ended
Dec. 30, 2018
Balance Sheet Related Disclosures [Abstract]  
Accounts Receivable
Accounts Receivable (in millions)
 
 
 
 
December 30,
2018
 
September 30,
2018
Trade, net of allowances for doubtful accounts of $47 and $56, respectively
$
2,330

 
$
2,667

Unbilled receivables
1,072

 
201

Other
24

 
36

 
$
3,426

 
$
2,904

Inventories
Inventories (in millions)
 
 
 
 
December 30,
2018
 
September 30,
2018
Raw materials
$
79

 
$
72

Work-in-process
763

 
715

Finished goods
856

 
906

 
$
1,698

 
$
1,693

Equity Method and Non-Marketable Equity Investments
The carrying values of our equity method and non-marketable equity investments are recorded in other noncurrent assets and were as follows (in millions):
 
December 30,
2018
 
September 30,
2018
Equity method investments
$
386

 
$
402

Non-marketable equity investments
708

 
650

 
$
1,094

 
$
1,052

Other Current Liabilities
Other Current Liabilities (in millions)
 
 
 
 
December 30,
2018
 
September 30,
2018
Customer incentives and other customer-related liabilities
$
3,494

 
$
3,500

Accrual for EC fine (Note 6)
1,155

 
1,167

Income taxes payable
484

 
453

RF360 Holdings put and call option
1,141

 
1,137

Other
557

 
721

 
$
6,831

 
$
6,978


Investment and Other Income, Net
Investment and Other Income, Net (in millions)
 
 
 
 
Three Months Ended
 
December 30,
2018
 
December 24,
2017
Interest and dividend income
$
74

 
$
126

Net (losses) gains on marketable securities
(72
)
 
10

Net gains on other investments
35

 
13

Impairment losses on marketable securities and other investments
(9
)
 
(9
)
Net losses on derivative investments
(8
)
 
(1
)
Equity in net losses of investees
(21
)
 
(21
)
Net gains (losses) on foreign currency transactions
6

 
(4
)
 
$
5

 
$
114